Argent Biopharma Limited has released a press release.
New Distribution Agreements Signed for CannEpil & IMPs
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Argent Biopharma
- Agreement for CBD Nutraceuticals Entry into China Market
- Received CannEpil Purchase Orders and Import Permit for UK
- MXCs 2019 Pharma Commercialisation Strategy
- Independent Validation of MXC High-Grade Cannabis Genetics
- MXC Botanical Update
Later from Argent Biopharma
- UK Distribution Agreement with Grow Biotech and IPS
- Arrival of First CannEpil Shipment to United Kingdom
- Cultivation Licence Granted by the Office of Drug Control
- Material Revenues Confirmed from Non-Pharma Business Units
- Pharma Update - Increased Orders and Clinical Study
Follow Argent Biopharma into a list and get an email when it puts out news.
Follow Argent Biopharma